Featured product: Occlusafe® Temporary Occlusion Balloon Catheter
A total of 31 patients received 70 sessions of B-TACE using a 1.8-Fr tip micro balloon catheter Occlusafe®.
The overall technical success rate was 99% (69 out of 70 sessions).
As procedural complications, rupture of the micro balloon (n = 3) and aneurysmal dilatation at the site of balloon occlusion (n = 2) were encountered.
There were no significant differences in any parameters between blood biochemical examination before and between two to four weeks after the procedure.
A 1.8-Fr tip micro balloon catheter Occlusafe® enables selective catheterization in patients with HCC and B-TACE using the 1.8-Fr tip micro balloon catheter is a safe procedure
This is HCP only content
website and cannot be refused. Other cookies are only placed if you choose to do so. For further information, please read our cookies policy.
Essential cookies to ensure the website functions well.
Cookies to help us measure the general use of our website.
Cookies that save personal information while browsing.